Sale!

IHC ER-PRHER2NEU Test Cost

Original price was: 1,200 د.إ.Current price is: 900 د.إ.

-25%

The IHC ER-PRHER2NEU Test is a comprehensive diagnostic tool used in assessing breast cancer characteristics and determining the most effective treatment plan for patients. This test involves Immunohistochemistry (IHC) to evaluate the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) in breast cancer tissue. These markers are crucial in identifying hormone receptor-positive or HER2-positive breast cancers, which can significantly influence treatment decisions, including the use of hormone therapy or targeted therapy.

Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the test ensures precision and reliability. The cost of the IHC ER-PRHER2NEU Test at DNA Labs UAE is 900 AED. This investment in accurate diagnosis can lead to personalized treatment plans that improve patient outcomes, making it a valuable tool in the management of breast cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IHC ER-PRHER2NEU Test Cost AED:900.0

Are you looking for information on the IHC ER-PRHER2NEU test cost in UAE? Look no further! DNA Labs UAE offers this test at a competitive price of 900.0 AED.

What is the IHC ER-PRHER2NEU Test?

The IHC ER-PRHER2NEU test, also known as immunohistochemistry testing, is used to determine the expression of certain biomarkers in breast cancer cells. This test helps in determining the prognosis and treatment options for breast cancer patients.

Components of the Test

  • Tissue in 10% Neutral Buffered Formalin or Block

Sample Condition

Tissue/Paraffin block

Report Delivery

The report for the IHC ER-PRHER2NEU test will be delivered within 3 days.

Method and Test Type

The IHC ER-PRHER2NEU test is conducted using the IHC method. It falls under the genetics test category.

Doctor and Test Department

This test is performed by oncologists in the test department.

Pre Test Information

The IHC ER-PRHER2NEU test can be done with a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or for people planning to travel abroad.

Understanding the Test

The IHC ER-PRHER2NEU test focuses on three biomarkers: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2NEU). These biomarkers play a crucial role in determining the growth and treatment options for breast cancer.

ER and PR are hormone receptors that indicate whether the cancer cells are dependent on estrogen and progesterone for growth. HER2NEU is a protein that promotes cell growth and is often overexpressed in certain breast cancer subtypes.

The IHC testing process involves staining tissue samples with specific antibodies that bind to these biomarkers. The stained cells are then examined under a microscope to determine the presence and extent of ER, PR, and HER2 expression.

This valuable information helps guide treatment decisions, such as hormone therapy or targeted therapies that specifically target HER2.

If you suspect breast cancer or need further information about the IHC ER-PRHER2NEU test, consult an oncologist at DNA Labs UAE today!

Test Name IHC ER-PRHER2NEU Test
Components Tissue In 10%Neutral Buffered Formalin Or Block
Price 900.0 AED
Sample Condition Tissue\/ Paraffin block
Report Delivery 3 days
Method IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information IHC ER-PR,HER2NEU can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

IHC ER-PR, HER2NEU refers to a type of immunohistochemistry (IHC) testing used to determine the expression of certain biomarkers in breast cancer cells. ER stands for estrogen receptor, PR stands for progesterone receptor, and HER2NEU refers to the human epidermal growth factor receptor 2 (HER2).

These biomarkers are important in determining the prognosis and treatment options for breast cancer patients. ER and PR are hormone receptors that indicate whether the cancer cells are dependent on estrogen and progesterone for growth. HER2 is a protein that promotes cell growth and is often overexpressed in certain breast cancer subtypes.

IHC testing involves staining tissue samples with specific antibodies that bind to these biomarkers. The stained cells are then examined under a microscope to determine the presence and extent of expression of ER, PR, and HER2. This information helps guide treatment decisions, such as hormone therapy or targeted therapies that specifically target HER2.